 Clark Sims
Concepts (165)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Milk, Human | 11 | 2026 | 122 | 1.890 |
Why?
| | Body Composition | 10 | 2026 | 355 | 1.030 |
Why?
| | Body Mass Index | 8 | 2024 | 717 | 0.910 |
Why?
| | Breast Feeding | 7 | 2024 | 203 | 0.880 |
Why?
| | Fluorocarbons | 1 | 2025 | 65 | 0.850 |
Why?
| | Maternal Exposure | 1 | 2025 | 103 | 0.850 |
Why?
| | Sepsis | 3 | 2016 | 240 | 0.820 |
Why?
| | Environmental Pollutants | 1 | 2025 | 110 | 0.820 |
Why?
| | Adiposity | 6 | 2024 | 147 | 0.710 |
Why?
| | Postpartum Period | 3 | 2021 | 111 | 0.680 |
Why?
| | Obesity | 10 | 2025 | 1204 | 0.610 |
Why?
| | Pregnancy | 15 | 2026 | 2608 | 0.540 |
Why?
| | Oligosaccharides | 4 | 2022 | 33 | 0.540 |
Why?
| | Longitudinal Studies | 7 | 2025 | 774 | 0.530 |
Why?
| | Organophosphorus Compounds | 1 | 2014 | 18 | 0.430 |
Why?
| | Overweight | 5 | 2024 | 232 | 0.420 |
Why?
| | Infant | 15 | 2026 | 3805 | 0.420 |
Why?
| | Piperidines | 1 | 2014 | 98 | 0.410 |
Why?
| | Milk | 3 | 2023 | 84 | 0.380 |
Why?
| | Antioxidants | 1 | 2014 | 264 | 0.370 |
Why?
| | Female | 28 | 2026 | 28782 | 0.370 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2021 | 64 | 0.320 |
Why?
| | Pregnancy Complications | 3 | 2025 | 406 | 0.320 |
Why?
| | Mitochondria | 1 | 2014 | 446 | 0.320 |
Why?
| | Acute Kidney Injury | 1 | 2014 | 399 | 0.310 |
Why?
| | Humans | 29 | 2026 | 53230 | 0.300 |
Why?
| | Leptin | 2 | 2022 | 151 | 0.290 |
Why?
| | Adult | 15 | 2026 | 14534 | 0.290 |
Why?
| | Diet | 4 | 2024 | 610 | 0.240 |
Why?
| | Fatty Acids, Volatile | 1 | 2026 | 16 | 0.240 |
Why?
| | Infant Formula | 3 | 2024 | 154 | 0.240 |
Why?
| | RNA Stability | 1 | 2026 | 29 | 0.240 |
Why?
| | Specimen Handling | 1 | 2026 | 63 | 0.230 |
Why?
| | Pregnancy Trimesters | 1 | 2025 | 13 | 0.230 |
Why?
| | Alkanesulfonic Acids | 1 | 2025 | 11 | 0.230 |
Why?
| | Fatty Acids | 1 | 2026 | 154 | 0.230 |
Why?
| | Mothers | 2 | 2024 | 269 | 0.220 |
Why?
| | RNA | 1 | 2026 | 173 | 0.220 |
Why?
| | Exercise Therapy | 1 | 2025 | 105 | 0.220 |
Why?
| | Temperament | 1 | 2024 | 23 | 0.220 |
Why?
| | Pregnancy Outcome | 1 | 2025 | 231 | 0.210 |
Why?
| | Lactation | 2 | 2020 | 66 | 0.200 |
Why?
| | Child, Preschool | 8 | 2024 | 4162 | 0.200 |
Why?
| | Inflammation | 2 | 2026 | 652 | 0.200 |
Why?
| | Intention | 1 | 2023 | 51 | 0.190 |
Why?
| | Absorptiometry, Photon | 2 | 2020 | 160 | 0.190 |
Why?
| | Infant, Newborn | 7 | 2026 | 2913 | 0.190 |
Why?
| | Isoleucine | 1 | 2021 | 27 | 0.180 |
Why?
| | Body Weight | 2 | 2021 | 524 | 0.180 |
Why?
| | Monosaccharides | 1 | 2020 | 7 | 0.170 |
Why?
| | Urinalysis | 1 | 2020 | 33 | 0.170 |
Why?
| | Infant Food | 1 | 2020 | 28 | 0.160 |
Why?
| | Growth | 1 | 2020 | 40 | 0.160 |
Why?
| | Bottle Feeding | 1 | 2020 | 34 | 0.160 |
Why?
| | Pregnancy Trimester, Third | 1 | 2020 | 51 | 0.160 |
Why?
| | Disease Models, Animal | 2 | 2016 | 1517 | 0.160 |
Why?
| | Plethysmography | 1 | 2020 | 43 | 0.160 |
Why?
| | Young Adult | 3 | 2025 | 4511 | 0.160 |
Why?
| | Physical Conditioning, Animal | 1 | 2020 | 67 | 0.160 |
Why?
| | Metabolome | 1 | 2020 | 107 | 0.160 |
Why?
| | Arkansas | 1 | 2025 | 2068 | 0.150 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2020 | 250 | 0.150 |
Why?
| | Animals | 7 | 2023 | 13526 | 0.140 |
Why?
| | Male | 13 | 2026 | 27435 | 0.140 |
Why?
| | Child Development | 1 | 2021 | 215 | 0.140 |
Why?
| | Health Status | 1 | 2020 | 306 | 0.140 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2024 | 115 | 0.140 |
Why?
| | Adipose Tissue | 1 | 2020 | 210 | 0.140 |
Why?
| | Heart | 1 | 2020 | 350 | 0.130 |
Why?
| | Follicular Fluid | 1 | 2017 | 9 | 0.130 |
Why?
| | Anthropometry | 3 | 2022 | 101 | 0.130 |
Why?
| | Oocytes | 1 | 2017 | 95 | 0.120 |
Why?
| | Parents | 1 | 2019 | 341 | 0.120 |
Why?
| | C-Reactive Protein | 1 | 2017 | 152 | 0.120 |
Why?
| | Weight Gain | 3 | 2023 | 245 | 0.120 |
Why?
| | Triglycerides | 1 | 2017 | 171 | 0.120 |
Why?
| | Receptors, Lysosphingolipid | 1 | 2014 | 7 | 0.110 |
Why?
| | Microcirculation | 1 | 2014 | 63 | 0.110 |
Why?
| | Critical Care | 1 | 2016 | 215 | 0.100 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 138 | 0.100 |
Why?
| | Central Nervous System Depressants | 1 | 2013 | 77 | 0.100 |
Why?
| | Energy Metabolism | 2 | 2026 | 324 | 0.100 |
Why?
| | Mice | 4 | 2020 | 5982 | 0.100 |
Why?
| | Membrane Glycoproteins | 1 | 2013 | 238 | 0.090 |
Why?
| | Child | 5 | 2023 | 7379 | 0.090 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 421 | 0.090 |
Why?
| | Bone Resorption | 1 | 2013 | 304 | 0.090 |
Why?
| | Ethanol | 1 | 2013 | 338 | 0.090 |
Why?
| | Kidney | 1 | 2014 | 715 | 0.080 |
Why?
| | Linear Models | 2 | 2021 | 287 | 0.080 |
Why?
| | Metabolomics | 2 | 2020 | 155 | 0.070 |
Why?
| | Insulin | 2 | 2022 | 493 | 0.070 |
Why?
| | Rats | 1 | 2014 | 3162 | 0.070 |
Why?
| | Exercise | 2 | 2024 | 561 | 0.070 |
Why?
| | Cohort Studies | 2 | 2024 | 1557 | 0.070 |
Why?
| | Exercise Test | 1 | 2025 | 137 | 0.060 |
Why?
| | Time Factors | 2 | 2026 | 2991 | 0.060 |
Why?
| | Resistance Training | 1 | 2025 | 106 | 0.050 |
Why?
| | Oxygen Consumption | 1 | 2025 | 201 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2020 | 910 | 0.050 |
Why?
| | Fathers | 1 | 2024 | 27 | 0.050 |
Why?
| | Mother-Child Relations | 1 | 2024 | 55 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2024 | 122 | 0.050 |
Why?
| | Vitamins | 1 | 2023 | 64 | 0.050 |
Why?
| | Osteocalcin | 1 | 2023 | 45 | 0.050 |
Why?
| | Food, Formulated | 1 | 2023 | 41 | 0.050 |
Why?
| | Nutrition Surveys | 1 | 2023 | 118 | 0.050 |
Why?
| | Palmitates | 1 | 2022 | 28 | 0.050 |
Why?
| | Stress, Psychological | 1 | 2024 | 282 | 0.050 |
Why?
| | Butyrates | 1 | 2022 | 30 | 0.050 |
Why?
| | Feeding Behavior | 1 | 2024 | 195 | 0.050 |
Why?
| | Gene Expression | 1 | 2024 | 618 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 1925 | 0.040 |
Why?
| | Lipids | 1 | 2022 | 163 | 0.040 |
Why?
| | MicroRNAs | 1 | 2026 | 397 | 0.040 |
Why?
| | Leucine | 1 | 2021 | 114 | 0.040 |
Why?
| | Feces | 1 | 2021 | 159 | 0.040 |
Why?
| | Cattle | 1 | 2020 | 207 | 0.040 |
Why?
| | Depression | 1 | 2025 | 621 | 0.040 |
Why?
| | Bacteria | 1 | 2022 | 226 | 0.040 |
Why?
| | Eating | 1 | 2021 | 159 | 0.040 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2020 | 62 | 0.040 |
Why?
| | Mental Disorders | 1 | 2024 | 446 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2019 | 141 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 333 | 0.040 |
Why?
| | Homeostasis | 1 | 2020 | 209 | 0.040 |
Why?
| | Soybean Proteins | 1 | 2020 | 167 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 501 | 0.040 |
Why?
| | Insulin Resistance | 1 | 2020 | 282 | 0.040 |
Why?
| | Gestational Age | 1 | 2019 | 394 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2020 | 243 | 0.030 |
Why?
| | Oocyte Retrieval | 1 | 2017 | 5 | 0.030 |
Why?
| | Models, Biological | 1 | 2020 | 737 | 0.030 |
Why?
| | Blood Glucose | 1 | 2020 | 490 | 0.030 |
Why?
| | Chemokine CXCL2 | 1 | 2017 | 11 | 0.030 |
Why?
| | Ovulation Induction | 1 | 2017 | 11 | 0.030 |
Why?
| | Inhibitor of Differentiation Proteins | 1 | 2017 | 6 | 0.030 |
Why?
| | Dual Specificity Phosphatase 1 | 1 | 2017 | 8 | 0.030 |
Why?
| | Myocardium | 1 | 2020 | 471 | 0.030 |
Why?
| | Phenotype | 1 | 2020 | 803 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2017 | 72 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 96 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2017 | 189 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 1003 | 0.030 |
Why?
| | Risk Factors | 1 | 2024 | 4017 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2017 | 193 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2017 | 315 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2017 | 330 | 0.030 |
Why?
| | Oxadiazoles | 1 | 2014 | 9 | 0.030 |
Why?
| | Ligation | 1 | 2014 | 63 | 0.030 |
Why?
| | Punctures | 1 | 2014 | 52 | 0.030 |
Why?
| | Permeability | 1 | 2014 | 70 | 0.030 |
Why?
| | Capillaries | 1 | 2014 | 53 | 0.030 |
Why?
| | Thiophenes | 1 | 2014 | 45 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2017 | 1212 | 0.030 |
Why?
| | Pyrazoles | 1 | 2014 | 123 | 0.030 |
Why?
| | Pyridines | 1 | 2014 | 135 | 0.020 |
Why?
| | Random Allocation | 1 | 2013 | 284 | 0.020 |
Why?
| | RANK Ligand | 1 | 2013 | 188 | 0.020 |
Why?
| | Genotype | 1 | 2013 | 563 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1112 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 1367 | 0.020 |
Why?
| | Osteogenesis | 1 | 2013 | 374 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2013 | 1569 | 0.020 |
Why?
| | Adolescent | 1 | 2017 | 6907 | 0.010 |
Why?
|
|
Sims's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|